drugset / Trial / NCT07302815

Preemptive Intravenous Micro-dose Dexmedetomidine to Prevent Emergence Agitation in Adult Patients Undergoing Septoplasty Surgeries

NCT07302815 ↗

Active not recruiting 120 enrolled Tanta University
RandomizedParallel-groupDouble-blindPrevention

Summary

This prospective randomized controlled study will be conducted to evaluate the effect of preoperative single, micro-dose of dexmedetomidine (0.3μg/kg) on the incidence and severity of EA in adults undergoing Septoplasty surgeries

Timeline

Start
2026-01-10
Primary completion
2026-07-10
Completion
2026-07-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.3 ug/kg Intravenous

Indications

No indication recorded.